In December 2006, VINNOVA was commissioned by the Swedish Government to carry out an international study to shed light on the competitiveness of the Swedish sectorial innovation systems of pharmaceuticals, biotechnology and medical technology.The present report is one of the studies carried out as part of the project. The aim is to analyse the structure, dynamics and performance of the life science industry.
This study reports on approximately 617 companies with 34,400 employees in the life science industry in Sweden involved in manufacturing, consultancy, product development and/or research and development (R&D). It gives a snapshot of these companies’ activities in Sweden in 2006, grouped by business segment, type of activity and region.
Together, the cluster profiles, employment development and economic development, give insights into the size, structure, development and performance of the Swedish life science industry for 1997-2006. Overall, the 1997-2003 development was strong: production grew significantly, the estimated average growth rate was high and the number of employees increased. However, the 2003-2006 development has been much weaker, especially in terms of employment development.
The project manager of this commission is Anna Sandström at the Strategy Development Division of VINNOVA and the authors of the report are Anna Sandström and Helena Bergqvist, VINNOVA and Tage Dolk, Addendi AB.
VINNOVA Analysis: http://www.vinnova.se/In-English/Publications/Products-hidden/15210/
Tillbaka till Projekt